牛黄制剂用于治疗大面积脑梗死继发高热的效果

吴锦涛

（城固县中医医院，陕西 汉中，723200）

浏览次数：149次 下载次数：380次

摘要：

目的 观察在常规性治疗的基础上使用牛黄制剂治疗大面积脑梗死继发高热的临床效果。方法 选取2016 年1 月 至2017 年4 月到医院接受合并继发性高热大面积脑梗死50 例患者为研究对象，采取随机分配的方式将其划分成对照组和 观察组，每组25 例。其中对照组的患者接受常规性的治疗，观察组的患者在此基础上添加牛黄丸进行治疗，对比两组患者的 治疗效果。结果 观察组患者的治疗总有效率（88.0%）明显高于对照组（60.0%）（P<0.05）。观察组患者的体温和意识恢复时间 14 d 以上所占比例低于对照组，且患者的平均恢复时间短于对照组（P<0.05）。结论 治疗大面积脑梗死继发性高热时在 常规治疗的基础上采用牛黄制剂，能够有效控制患者的体温，对于患者的康复和治疗具有重要的意义，在临床治疗中值 得推广使用。

关键词：牛黄制剂；脑梗死；高热

中图分类号：R277.7文献标志码：A文章编号：2096-1413(2018)06-0123-02

Effect of bezoar preparation on secondary high fever of massive cerebral infarction


WU Jin-tao
(Traditional Chinese Medicine Hospital of Chenggu County, Hanzhong 723200, China)

ABSTRACT: Objective To observe the clinical effect of bezoar preparation on secondary high fever of massive cerebral infarction on the basis of routine treatment. Methods From January 2016 to April 2017, 50 patients with secondary high fever of massive cerebral infarction were selected as the research objects, and randomly divided into control group and observation group, with 25 cases in each group. The control group received routine treatment, on this basis, the observation group was treated with Niuhuangwan. The treatment effects were compared in the two groups. Results The total effective rate in the observation group (88.0%) was significantly higher than that in the control group (60.0%) (P<0.05). The body temperature and consciousness recovery time rate in more than 14 d of the observation group were significantly lower than those in the control group, and its average recovery time was shorter than that of the control group (P<0.05). Conclusion In the treatment of secondary high fever of massive cerebral infarction, using bezoar preparation on the basis of the routine treatment can effectively control the patients`` body temperature, it has great significance in the patients`` rehabilitation and treatment and worth being popularized in clinic.
KEYWORDS: bezoar preparation; cerebral infarction; high fever

参考文献：
[1] 税国保.关于牛黄制剂应用于高热中的临床观察[J].健康大视野,2013,21(5):19-20.
[2] 吴云虎.安宫牛黄丸对大面积脑梗死急性期患者血中ADMA 水平的影响[J].中医药临床杂志,2015,27(2):177-179.
[3] 黄绮芸.用安宫牛黄丸联合醒脑静注射液治疗大面积脑梗死继发高热的效果分析[J].当代医药论丛,2015,13(15):189-190.
[4] 李为,李喜平,张程亮,等.牛黄复方及其制剂的研究进展[J].中国药师,2015,18(10):1784-1787.
[5] 刘晓明,高善语.安宫牛黄制剂治疗老年急性脑梗死的临床观察[J].光明中医,2016,31(17):2462-2465.
[6] 王红梅,李莲,罗亚萍.安宫牛黄丸治疗脑出血患者高热、昏迷的临床疗效观察[J].中国医药指南,2012,10(26):235-236.